First, we analyzed the safety signal for sepsis when ADCs were co-administrated with the granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF), proton pump inhibitors, H2-receptor antagonists, and CYP3A4/5 strong inhibitors. This evidence concerns the gene CSF2 and Sepsis.